Efficacy of Ultrasound-Guided PRP Versus Corticosteroid Injection in Patients With Ulnar Neuropathy at Elbow
NCT ID: NCT05567081
Last Updated: 2022-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
60 participants
INTERVENTIONAL
2021-06-01
2022-07-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients were be randomly divided into 2 groups:
Group I: will undergo a single ultrasound-guided deep perineural injection with 3ml PRP at the thickest part of the ulnar nerve. PRP will be prepared by PRP method.
Group II: will undergo a single ultrasound-guided deep perineural injection with 1ml corticosteroid (triamcinolone acetonide, 40mg/mL) mixed with 1ml lidocaine hydrochloride.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perineural Injection Therapy for Ulnar Neuropathy at Elbow
NCT02986906
Ultrasound-guided PRP Versus Steroid Injections in Management of Carpal Tunnel Syndrome
NCT04434105
Platelet-rich Plasma Injection for Ulnar Neuropathy at Elbow
NCT04264000
The Effect of Perineural Dextrose Injection in Patients With Ulnar Neuropathy at the Elbow
NCT03737916
Study of Single Platelet-Rich Plasma Local Injection Vs. Single Corticosteroid Local Injection in Carpal Tunnel Syndrome
NCT06209957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRP group
3 cm of autologous platelet rich plasma injected once around the thickest part of ulnar nerve.
PRP
Deep perineural injection with 3ml PRP at the thickest part of the ulnar nerve.
Corticosteroid group
Triamcinolone Acetonide 40mg/mL (1ml) mixed with 1ml lidocaine hydrochloride injected once around the thickest part of ulnar nerve.
Triamcinolone Acetonide 40mg/mL
Deep perineural injection with 1cm corticosteroid mixed with 1ml lidocaine hydrochloride.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triamcinolone Acetonide 40mg/mL
Deep perineural injection with 1cm corticosteroid mixed with 1ml lidocaine hydrochloride.
PRP
Deep perineural injection with 3ml PRP at the thickest part of the ulnar nerve.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Brachial plexopathy, peripheral neuropathy, and cervical radiculopathy.
3. History of recent elbow trauma or operation.
4. Malignant neoplasm.
5. Pregnancy.
6. Bleeding Disorders.
7. Factors affecting nerve healing process e.g., tobacco use and systemic corticosteroid administration.
8. Contraindications for PRP injection:
1. Significant renal or hepatic dysfunction.
2. Critical thrombocytopenia.
3. Hemodynamic instability.
4. Septicemia.
5. Local infection at the site of the procedure.
6. Consistent use of nonsteroidal anti-inflammatory drugs within the last two weeks.
7. Local injection at the suspected treatment site within the last month.
8. Recent fever or illness.
9. Hemoglobin level \<10 g/dL.
10. Platelet dysfunction disorders.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hajar Anwer Elnagar
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta University Hospital
Tanta, Gharbia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
34743/6/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.